Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase III study of TH-9507 for HIV-associated lipodystrophy cleared to continue

July 11, 2006

Tentative approval for generic three-in-one antiretroviral product

July 7, 2006

Study finds no resistance mutations with bevirimat in HIV patients

July 5, 2006

Review of intracranial hemorrhage reports in Aptivus clinical trials

July 5, 2006

European approval for Kaletra tablet

July 4, 2006

Characterization of SPI-256 mutational escape pathways

July 4, 2006

Oncolys Biopharma licenses Ed4T for HIV-1 from Yale University

July 4, 2006

Novel HIV fusion inhibitors active against enfuvirtide-resistant viruses

July 3, 2006

Novel mutation pattern for the protease inhibitor PL-100 identified

July 3, 2006

Prezista launched in U.S. for treatment of antiretroviral-treatment experienced patients

July 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...